Press releases
- Nordic Nanovector - Notice of Annual General Meeting on 28 June 2023
- Nordic Nanovector announces agreement to acquire Thor Medical, an emerging producer of alpha-emitters for radiopharmaceuticals to treat cancer
- Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database
- NORDIC NANOVECTOR - ANNUAL GENERAL MEETING POSTPONED
- NORDIC NANOVECTOR - ANNUAL AND REMUNERATION REPORTS APPROVED
More ▼
Key statistics
On Wednesday, Nordic Nanovector ASA (8NN:DEU) closed at 0.132, 277.14% above the 52 week low of 0.035 set on May 19, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.076 |
---|---|
High | 0.132 |
Low | 0.054 |
Bid | 0.131 |
Offer | 0.133 |
Previous close | 0.084 |
Average volume | 1.22k |
---|---|
Shares outstanding | 116.04m |
Free float | 97.05m |
P/E (TTM) | -- |
Market cap | 111.28m NOK |
EPS (TTM) | -2.70 NOK |
Data delayed at least 15 minutes, as of Jun 07 2023 18:05 BST.
More ▼